ASH 2014: Phase III study shows that brentuximab improves progression-free survival in Hodgkin lymphoma - 101271

Spotlight
Video

ASH 2014: Phase III study shows that brentuximab improves progression-free survival in Hodgkin lymphoma

EMJ has 458 videos Subscribe Here

Loading........
Description: At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY) presents results from the phase III AETHERA trial, which evaluated the safety and efficacy of brentuximab vedotin in preventing post-autologous stem cell transplant disease recurrence in Hodgkin lymphoma patients.
Shared By : EMJ
Posted on : 12/09/14
Added : 3 years ago



More From EMJ

Nothing found.